Adverse Events Associated with Disease-Modifying Drugs for Multiple SclerosisNeurol 102:e208006, Ng, HS.,et al, 2024
Randomized Trial of Oral Teriflunomide for Relapsing Multiple SclerosisNEJM 365:1293-1303, OConnor, P.,et al, 2011